Post-collection, pre-measurement variables affecting VEGF levels in urine biospecimens.
Angiogenesis, the development and recruitment of new blood vessels, plays an important role in tumour growth and metastasis. Vascular endothelial growth factor (VEGF) is an important stimulator of angiogenesis. Circulating and urinary VEGF levels have been suggested as clinically useful predictors of tumour behaviour, and investigations into these associations are ongoing. Despite recent interest in measuring VEGF levels in patients, little is known about the factors that influence VEGF levels in biospecimens. To begin to address this question, urine samples were collected from patients with solid tumours undergoing radiotherapy and healthy volunteers. Four factors were examined for their effects on VEGF concentrations as measured by chemiluminescent immunoassay: time from sample collection to freezing, number of specimen freeze-thaw cycles, specimen storage tube type and the inclusion or exclusion of urinary sediment. The results of this study indicate that time to freeze up to 4 hrs, number of freeze-thaw cycles between one and five, and different types of polypropylene tubes did not have statistically significant effects on measured urinary VEGF levels. Urinary sediment had higher VEGF levels than supernatant in five of six samples from healthy patients. It is not clear whether there is an active agent in the sediment causing this increase or if the sediment particles themselves are affecting the accuracy of the assay.Therefore, we recommend centrifuging urine, isolating the supernatant, and freezing the sample in polypropylene microcentrifuge tubes or cryogenic vials within 4 hrs of collection.In addition, we recommend the use of samples within five freeze-thaw cycles.
Hayward
Robert M
RM
Radiation Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892-1002, USA.
Kirk
Melissa J
MJ
Sproull
Mary
M
Scott
Tamalee
T
Smith
Sharon
S
Cooley-Zgela
Theresa
T
Crouse
Nancy S
NS
Citrin
Deborah E
DE
Camphausen
Kevin
K
D014408:Biomarkers, Tumor / Q000652:urine*; D005615:Freezing; D006801:Humans; D009369:Neoplasms / Q000532:radiotherapy / Q000652:urine*; D011126:Polypropylenes / Q000737:chemistry; D013048:Specimen Handling; D042461:Vascular Endothelial Growth Factor A / Q000652:urine*
D014408:Biomarkers, Tumor; D011126:Polypropylenes; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A